Teva Pharma (TEVA) stock gains as the company and Samsung Bioepis launch Epysqli, a biosimilar to AstraZeneca's (AZN) rare ...

Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization ...

Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and ...

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

The AstraZeneca PLC ADR AZN slid 7.39% to $68.46 Friday, on what proved to be an all-around poor trading session for the ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

FTSE shares moved lower on 3 April, after US President Donald Trump introduced hefty tariffs on its trading partners. These ...

AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and ...

AstraZeneca PLC closed 16.13% short of its 52-week high of £133.88, which the company reached on September 3rd.

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition ...